Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Businessweek Archives

Cordis' Cold Shoulder


In Business This Week

CORDIS' COLD SHOULDER

CORDIS ISN'T SURRENDERING without a fight. The $443 million manufacturer of medical devices on Nov. 1 rejected as inadequate Johnson & Johnson's $1.7 billion hostile takeover bid, announced two weeks earlier. J&J, which made its move after failing to spark interest in a friendly deal, is eyeing Cordis' line of angioplasty balloons, which would complement J&J's own stents, minute coils that prop up open arteries. Cordis stock jumped to $112 on speculation that J&J would sweeten its bid or that a competing offer may be in the works.EDITED BY KEITH H. HAMMONDS


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus